Michael Zezas: The Risks of a U.S. Government Shutdown

Michael Zezas: The Risks of a U.S. Government Shutdown

Although Congress has avoided previous shutdowns with last-minute resolutions, investors shouldn’t get complacent in assuming the same outcome again in the fall.


----- Transcript -----

Welcome to Thoughts on the Market. I'm Michael Zezas, Global Head of Fixed Income and Thematic Research for Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about what investors need to know about the risk of the U.S. government shutdown. It's Wednesday, August 16th at 10 a.m. in New York.


Congress is in recess until September. When they return, they'll have just a few weeks to pass several funding bills in order to avoid a government shutdown. And while it certainly seems like dramatic deadlines and last minute resolutions are all too common in D.C. these days, investors shouldn't get complacent on this one.


Let's start with why investors should take seriously the risk of a government shutdown, which happens when Congress fails to authorize spending to keep most government functions open. When that happens, there are both direct economic impacts, such as government workers and contractors not getting paid on time and indirect impacts, such as the economic activity of those workers and contractors being crimped given that they're going without pay. In the 2019 shutdown, for example, 800,000 government workers were affected by this disruption. Our economists estimate that for every week the government is shut down, we should expect a 0.05% point reduction in GDP, with that impact compounding and increasing over time. While that's not a huge number, in the context of an already softening economic growth and profit outlook for stocks, it doesn't help.


So if a shutdown presents economic downside, why is that even a possibility? Here's four reasons why. First, Congress faces several challenging negotiations in September, which elevates the complexity of the legislative process ahead of the shutdown deadline. Second, there are disagreements within the Republican Party on what the right level of funding is for the government, meaning one of the two parties has yet to firm up its position to get negotiations going in earnest. Third, there's also disagreement within the Republican Party on aid levels for Ukraine. Finally, there appears to be greater willingness on the part of lawmakers to engage in policy standoffs, as evidenced by the recent debt ceiling negotiation. While history shows that approval ratings for both parties fared poorly following a shutdown, shutdowns happen nonetheless, and quotes from key members of both parties suggest little concern with the political impact of such an event.


So what's an investor to do from here? For the moment, not much. We're not expecting much news on this or market reaction until September. Until then, we'll, of course, keep you updated on anything relevant.


Thanks for listening. If you enjoy the show, please share Thoughts on the Market with a friend or colleague, or leave us a review on Apple Podcasts. It helps more people find the show.

Episoder(1514)

Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies

Special Episode, Part 2: Coronavirus - Building Models to Rebuild Economies

When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.

14 Apr 202010min

Mike Wilson: U.S. Markets React to Fed Moves

Mike Wilson: U.S. Markets React to Fed Moves

If there is one lesson to be learned from the financial repression era it's that when risk premium appears, investors may want to make moves before it evaporates.

13 Apr 20204min

Special Episode: Coronavirus – Building Models to Rebuild Economies

Special Episode: Coronavirus – Building Models to Rebuild Economies

How do you track a virus, a global economy and a road to recovery? On this special episode, an engaging conversation with our Chief Cross-Asset Strategist and Head Biotech Equity Analyst.

9 Apr 20209min

Michael Zezas: Another Dose of Fiscal Stimulus?

Michael Zezas: Another Dose of Fiscal Stimulus?

The U.S. Congress has been debating ways to flatten another worrying curve: the sliding economic growth curve. What form could additional fiscal stimulus take?

8 Apr 20202min

Mike Wilson: What Are Markets Thinking?

Mike Wilson: What Are Markets Thinking?

Asset prices often reflect the obvious before it becomes obvious. So the question for investors now is, "What is the market thinking about that's not obvious?"

6 Apr 20203min

Andrew Sheets: Optimism for Credit Markets

Andrew Sheets: Optimism for Credit Markets

Even as economic and public health data get worse, recent changes in three key factors make global credit markets an attractive option. Our Chief Cross-Asset Strategist, Andrew Sheets, explains.

3 Apr 20202min

Michael Zezas: What Does the CARES Act Buy?

Michael Zezas: What Does the CARES Act Buy?

The $2 trillion CARES Act includes a variety of provisions that will help preserve the financial health of state and local governments, hospitals and airports. Here’s what’s inside.

1 Apr 20202min

Mike Wilson: U.S. Equities - Is the Worst Behind Us?

Mike Wilson: U.S. Equities - Is the Worst Behind Us?

Although economic and earnings data could be gloomy over the next month, have equity markets already discounted the bad news? Detailed analysis from Chief Investment Officer Mike Wilson.

30 Mar 20203min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
rss-borsmorgen-okonominyhetene
livet-pa-veien-med-jan-erik-larssen
rss-vass-knepp-show
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
utbytte
pengepodden-2
okonomiamatorene
morgenkaffen-med-finansavisen
aksjepodden
lederpodden
rss-markedspuls-2
rss-fri-kontantstrom
rss-impressions-2
stormkast-med-valebrokk-stordalen